Cargando…
HER2 gene status in primary breast cancers and matched distant metastases
INTRODUCTION: The status of the gene encoding human EGF-like receptor 2 (HER2) is an important prognostic and predictive marker in breast cancer. Only breast cancers with HER2 amplification respond to the targeted therapy with trastuzumab. It is controversial to what degree the primary tumour is rep...
Autores principales: | Tapia, Coya, Savic, Spasenija, Wagner, Urs, Schönegg, René, Novotny, Hedvika, Grilli, Bruno, Herzog, Michelle, Barascud, Audrey DeVito, Zlobec, Inti, Cathomas, Gieri, Terracciano, Luigi, Feichter, Georg, Bubendorf, Lukas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929093/ https://www.ncbi.nlm.nih.gov/pubmed/17511881 http://dx.doi.org/10.1186/bcr1676 |
Ejemplares similares
-
Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers
por: Savic, S, et al.
Publicado: (2008) -
Combined Simplified Molecular Classification of Gastric Adenocarcinoma, Enhanced by Lymph Node Status: An Integrative Approach
por: Daun, Till, et al.
Publicado: (2021) -
Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer
por: Cihoric, Nikola, et al.
Publicado: (2015) -
Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas
por: Matter, Matthias S., et al.
Publicado: (2020) -
Differential pattern and prognostic significance of CD4(+), FOXP3(+ )and IL-17(+ )tumor infiltrating lymphocytes in ductal and lobular breast cancers
por: Droeser, Raoul, et al.
Publicado: (2012)